Skip to main content

Frederick National Laboratory for Cancer Research

Thursday, October 11, 2012 — Poster Session IV

2:00 p.m. – 4:00 p.m.

Natcher Conference Center, Building 45




  • J Hartman


The Frederick National Laboratory for Cancer Research (FNL) offers a full range of cutting-edge research and development support to NIH scientists working in basic research, translational research, and preclinical studies. The Advanced Technology Program (ATP) offers the latest technology and expertise in genetics, genomics, proteins, proteomics, imaging, and nanotechnology. The Biopharmaceutical Development Program (BDP) provides state-of-the-art development of clinical-grade monoclonal antibodies, recombinant proteins, therapeutic peptides and plasmid DNA, oncolytic viruses, gene therapy products, and other biological agents. The Laboratory Animal Sciences Program (LASP) provides molecular technologies and model development, animal imaging, and conventional and molecular pathologic analysis. It provides complete, high-quality animal care and support services. The Advanced Biological Computing Center (ABCC) has computing infrastructure to support bioinformatics, molecular modeling, image analysis and high throughput information solutions. These programs are operated by FNL’s prime contractor, SAIC-Frederick, Inc. For more information about how these programs can support your research please contact: ATP, Dr. Bruce Crise (; BDP, Dr. John Gilly (; LASP, Dr. Lionel Feigenbaum (; ABCC, Dr. Jack Collins ( Website:

back to top